NICE enough? Do NICE’s Decision Outcomes Impact International HTA Decision-making?
External Expert Profile
Paul Dolan
Latest Publications
The Case for Expanding Uptake of Next-Generation Sequencing for Lung Cancer in Europe
A Novel Incentive Model for Uptake of Diagnostics to Combat Antimicrobial Resistance
Incentivising New Antibiotics: Designing a Value-Based Delinked Pull Incentive Mechanism
Proposal for a General Outcome-based Value Attribution Framework for Combination Therapies
Read more
© photoguns
